Total Payments
$28,856
2024 Payments
$2,610
Companies
59
Transactions
2,226
Medicare Patients
2,676
Medicare Billing
$337,061
Payment Breakdown by Category
Food & Beverage$27,267 (94.5%)
Other$1,375 (4.8%)
Education$214.47 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,267 | 2,216 | 94.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,375 | 1 | 4.8% |
| Education | $214.47 | 9 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,353 | 444 | $0 (2024) |
| Medtronic MiniMed, Inc. | $2,631 | 168 | $0 (2020) |
| Lilly USA, LLC | $2,190 | 168 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,903 | 202 | $0 (2024) |
| Amarin Pharma Inc. | $1,813 | 154 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,650 | 93 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,419 | 108 | $0 (2024) |
| Becton, Dickinson and Company | $1,216 | 65 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $1,134 | 79 | $0 (2024) |
| Amgen Inc. | $1,049 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,610 | 201 | Dexcom, Inc. ($334.56) |
| 2023 | $3,099 | 197 | Novo Nordisk Inc ($385.96) |
| 2022 | $3,489 | 260 | Novo Nordisk Inc ($764.86) |
| 2021 | $3,577 | 310 | Novo Nordisk Inc ($604.32) |
| 2020 | $3,343 | 268 | Amarin Pharma Inc. ($570.14) |
| 2019 | $4,893 | 303 | Medtronic MiniMed, Inc. ($1,796) |
| 2018 | $3,918 | 352 | Novo Nordisk Inc ($587.31) |
| 2017 | $3,926 | 335 | Novo Nordisk Inc ($800.06) |
All Payment Transactions
2,226 individual payment records from CMS Open Payments — Page 1 of 90
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $4.77 | General |
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $4.77 | General |
| 12/03/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $27.08 | General |
| 11/26/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $4.77 | General |
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $5.96 | General |
| 11/13/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $4.77 | General |
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $4.06 | General |
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 608 | 1,313 | $140,767 | $74,324 |
| 2022 | 5 | 648 | 1,452 | $144,994 | $80,893 |
| 2021 | 5 | 682 | 1,518 | $156,319 | $93,041 |
| 2020 | 6 | 738 | 1,611 | $143,486 | $88,804 |
Total Patients
2,676
Total Services
5,894
Medicare Billing
$337,061
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 364 | 762 | $118,815 | $66,324 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,565 | $2,913 | 52.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,385 | $1,879 | 55.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 32 | 72 | $4,680 | $1,802 | 38.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 172 | 439 | $8,322 | $1,406 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 384 | 839 | $121,655 | $71,434 | 58.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $7,215 | $4,081 | 56.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 16 | $3,600 | $2,380 | 66.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 188 | 508 | $9,144 | $1,639 | 17.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 28 | 52 | $3,380 | $1,358 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 407 | 887 | $126,245 | $78,140 | 61.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $9,135 | $5,727 | 62.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 27 | $6,075 | $4,229 | 69.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 59 | $5,900 | $3,317 | 56.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 190 | 498 | $8,964 | $1,629 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 411 | 867 | $99,705 | $64,983 | 65.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 133 | $13,300 | $7,744 | 58.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 42 | $9,450 | $6,807 | 72.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 51 | 51 | $9,435 | $5,857 | 62.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $2,560 | $1,785 | 69.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 197 | 502 | $9,036 | $1,627 | 18.0% |
About Dr. Eva Toth, MD
Dr. Eva Toth, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Cranberry Twp, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417985680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eva Toth, MD has received a total of $28,856 in payments from pharmaceutical and medical device companies, with $2,610 received in 2024. These payments were reported across 2,226 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($27,267).
As a Medicare-enrolled provider, Toth has provided services to 2,676 Medicare beneficiaries, totaling 5,894 services with total Medicare billing of $337,061. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Cranberry Twp, PA
- Active Since 06/28/2006
- Last Updated 07/20/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417985680
Products in Payments
- Ozempic (Drug) $2,004
- Vascepa (Drug) $1,813
- FARXIGA (Drug) $1,650
- Minimed 670G System (Device) $1,375
- JARDIANCE (Drug) $1,312
- UNITHROID (Drug) $1,300
- Minimed 530G (Device) $1,176
- TRADJENTA (Drug) $1,050
- BD Nano (Device) $962.59
- Korlym (Drug) $724.63
- Victoza (Drug) $717.43
- JANUVIA (Drug) $603.09
- BAQSIMI (Drug) $549.60
- TRULICITY (Drug) $528.35
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $518.65
- Dexcom G6 Transmitter (Medical Supply) $510.82
- CeQur Simplicity (Device) $444.20
- Repatha (Biological) $434.80
- INVOKANA (Drug) $416.42
- EVENITY (Biological) $398.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.